The Fight Against Antimicrobial Resistance: A Promising Broad Host-Range CRISPR-Cas9 Delivery Tool for AMR Plasmid Removal

FHS
June 21, 2023
7:38 am

Study removes AMR plasmids using a mobile, broad-host-range CRISPR-Cas9 delivery tool.

Cantourage Group SE (von NuWays AG) – Biotech Investments

Original-Research: Cantourage Group SE – from NuWays AG 10.10.2024 / 09:01 CET/CESTDissemination of a Research, transmitted by EQS News – a service of EQS Group

October 11, 2024

Columbia Care Q1 Revenue Drops 1% Sequentially

Columbia Care Reports First Quarter 2023 Results Quarterly Revenue of $125 Million, an Increase of 1% YoY Quarterly Gross Profit of Over $47 Million, an

May 15, 2023

BIOSECURE grandfather amendment softens US-China trade ban

An amendment to the US BIOSECURE bill will allow existing contracts with Chinese companies to be “grandfathered” in for eight years, reducing disruption to pharma

May 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.